Patients' preference and informed consent (Englisch)
- Neue Suche nach: Pumo, V.
- Neue Suche nach: Di Mari, A.
- Neue Suche nach: Rametta Giuliano, S.
- Neue Suche nach: Bordonaro, S.
- Neue Suche nach: Lanteri, E.
- Neue Suche nach: Tralongo, P.
- Neue Suche nach: Pumo, V.
- Neue Suche nach: Di Mari, A.
- Neue Suche nach: Rametta Giuliano, S.
- Neue Suche nach: Bordonaro, S.
- Neue Suche nach: Lanteri, E.
- Neue Suche nach: Tralongo, P.
In:
ANNALS OF ONCOLOGY
;
26
, 6
;
1269-1269
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Patients' preference and informed consent
-
Beteiligte:Pumo, V. ( Autor:in ) / Di Mari, A. ( Autor:in ) / Rametta Giuliano, S. ( Autor:in ) / Bordonaro, S. ( Autor:in ) / Lanteri, E. ( Autor:in ) / Tralongo, P. ( Autor:in )
-
Erschienen in:ANNALS OF ONCOLOGY ; 26, 6 ; 1269-1269
-
Verlag:
- Neue Suche nach: OXFORD UNIVERSITY PRESS
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:1 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.992
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.992 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 26, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1041
-
Prioritizing precision medicine for prostate cancerAttard, G. / Beltran, H. et al. | 2015
- 1043
-
Determining the indications for post mastectomy radiotherapy: moving from 20th century clinical staging to 21st century biological criteriaRussell, N. S. / Kunkler, I. H. / van Tienhoven, G. et al. | 2015
- 1045
-
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?Gallamini, A. / Kostakoglu, L. et al. | 2015
- 1048
-
Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?Woolf, D. K. / Padhani, A. R. / Makris, A. et al. | 2015
- 1058
-
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryMorrison, V. A. / Hamlin, P. / Soubeyran, P. / Stauder, R. / Wadhwa, P. / Aapro, M. / Lichtman, S. M. et al. | 2015
- 1069
-
Genetic lesions in diffuse large B-cell lymphomasTestoni, M. / Zucca, E. / Young, K. H. / Bertoni, F. et al. | 2015
- 1081
-
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive reviewJordan, K. / Jahn, F. / Aapro, M. et al. | 2015
- 1091
-
The prevalence and outcomes of frailty in older cancer patients: a systematic reviewHandforth, C. / Clegg, A. / Young, C. / Simpkins, S. / Seymour, M. T. / Selby, P. J. / Young, J. et al. | 2015
- 1101
-
Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studiesKeum, N. / Lee, D. H. / Kim, R. / Greenwood, D. C. / Giovannucci, E. L. et al. | 2015
- 1110
-
Integrative molecular profiling of routine clinical prostate cancer specimensGrasso, C. S. / Cani, A. K. / Hovelson, D. H. / Quist, M. J. / Douville, N. J. / Yadati, V. / Amin, A. M. / Nelson, P. S. / Betz, B. L. / Liu, C. J. et al. | 2015
- 1118
-
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaDavis, I. D. / Long, A. / Yip, S. / Espinoza, D. / Thompson, J. F. / Kichenadasse, G. / Harrison, M. / Lowenthal, R. M. / Pavlakis, N. / Azad, A. et al. | 2015
- 1123
-
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†Ravaud, A. / Oudard, S. / De Fromont, M. / Chevreau, C. / Gravis, G. / Zanetta, S. / Theodore, C. / Jimenez, M. / Sevin, E. / Laguerre, B. et al. | 2015
- 1128
-
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinomaIzzedine, H. / Derosa, L. / Le Teuff, G. / Albiges, L. / Escudier, B. et al. | 2015
- 1134
-
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analysesMitchell, P. / Thatcher, N. / Socinski, M. A. / Wasilewska-Tesluk, E. / Horwood, K. / Szczesna, A. / Martín, C. / Ragulin, Y. / Zukin, M. / Helwig, C. et al. | 2015
- 1142
-
A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancerLee, S. Y. / Choi, J. E. / Jeon, H. S. / Hong, M. J. / Choi, Y. Y. / Kang, H. G. / Yoo, S. S. / Lee, E. B. / Jeong, J. Y. / Lee, W. K. et al. | 2015
- 1149
-
No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based studyNordenskjöld, A. E. / Fohlin, H. / Albertsson, P. / Arnesson, L. G. / Chamalidou, C. / Einbeigi, Z. / Holmberg, E. / Nordenskjöld, B. / Karlsson, P. et al. | 2015
- 1155
-
Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapseHartkopf, A. D. / Wallwiener, M. / Fehm, T. N. / Hahn, M. / Walter, C. B. / Gruber, I. / Brucker, S. Y. / Taran, F. A. et al. | 2015
- 1161
-
Survival in stage I–III breast cancer patients by surgical treatment in a publicly funded health care systemFisher, S. / Gao, H. / Yasui, Y. / Dabbs, K. / Winget, M. et al. | 2015
- 1170
-
Phase II study of interim PET–CT-guided response-adapted therapy in advanced Hodgkin's lymphomaGanesan, P. / Rajendranath, R. / Kannan, K. / Radhakrishnan, V. / Ganesan, T. S. / Udupa, K. / Lakshmipathy, K. M. / Mahajan, V. / Sundersingh, S. / Rajaraman, S. et al. | 2015
- 1175
-
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomesCheah, C. Y. / Chihara, D. / Romaguera, J. E. / Fowler, N. H. / Seymour, J. F. / Hagemeister, F. B. / Champlin, R. E. / Wang, M. L. et al. | 2015
- 1180
-
A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemiaKorfi, K. / Mandal, A. / Furney, S. J. / Wiseman, D. / Somervaille, T. C. / Marais, R. et al. | 2015
- 1188
-
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord OvestCremolini, C. / Loupakis, F. / Antoniotti, C. / Lonardi, S. / Masi, G. / Salvatore, L. / Cortesi, E. / Tomasello, G. / Spadi, R. / Zaniboni, A. et al. | 2015
- 1194
-
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancerDeplanque, G. / Demarchi, M. / Hebbar, M. / Flynn, P. / Melichar, B. / Atkins, J. / Nowara, E. / Moyé, L. / Piquemal, D. / Ritter, D. et al. | 2015
- 1201
-
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trialPassardi, A. / Nanni, O. / Tassinari, D. / Turci, D. / Cavanna, L. / Fontana, A. / Ruscelli, S. / Mucciarini, C. / Lorusso, V. / Ragazzini, A. et al. | 2015
- 1208
-
Postoperative irinotecan in resected stage II–III rectal cancer: final analysis of the French R98 Intergroup trial†Delbaldo, C. / Ychou, M. / Zawadi, A. / Douillard, J. Y. / André, T. / Guerin-Meyer, V. / Rougier, P. / Dupuis, O. / Faroux, R. / Jouhaud, A. et al. | 2015
- 1216
-
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencingChung, C. H. / Guthrie, V. B. / Masica, D. L. / Tokheim, C. / Kang, H. / Richmon, J. / Agrawal, N. / Fakhry, C. / Quon, H. / Subramaniam, R. M. et al. | 2015
- 1223
-
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancerDeutsch, E. / Le Péchoux, C. / Faivre, L. / Rivera, S. / Tao, Y. / Pignon, J. P. / Angokai, M. / Bahleda, R. / Deandreis, D. / Angevin, E. et al. | 2015
- 1230
-
Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumorsChiorean, E. G. / Hurwitz, H. I. / Cohen, R. B. / Schwartz, J. D. / Dalal, R. P. / Fox, F. E. / Gao, L. / Sweeney, C. J. et al. | 2015
- 1238
-
Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patientsHecht, M. / Zimmer, L. / Loquai, C. / Weishaupt, C. / Gutzmer, R. / Schuster, B. / Gleisner, S. / Schulze, B. / Goldinger, S. M. / Berking, C. et al. | 2015
- 1244
-
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)Al-Batran, S. E. / Hozaeel, W. / Tauchert, F. K. / Hofheinz, R. D. / Hinke, A. / Windemuth-Kieselbach, C. / Hübner, A. / Burmester, M. / Koenigsmann, M. / Wiegand, J. et al. | 2015
- 1248
-
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind studyRoila, F. / Ruggeri, B. / Ballatori, E. / Fatigoni, S. / Caserta, C. / Licitra, L. / Mirabile, A. / Ionta, M. T. / Massidda, B. / Cavanna, L. et al. | 2015
- 1254
-
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trialFontein, D. B. / Klinten Grand, M. / Nortier, J. W. / Seynaeve, C. / Meershoek-Klein Kranenbarg, E. / Dirix, L. Y. / van de Velde, C. J. / Putter, H. et al. | 2015
- 1263
-
Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based dataCapocaccia, R. / Gatta, G. / Dal Maso, L. et al. | 2015
- 1269
-
Reply to the letter to the editor ‘Patients' preference and informed consent’ by Pumo et al.Pivot, X. / Machackova, Z. et al. | 2015
- 1269
-
Patients' preference and informed consentPumo, V. / Di Mari, A. / Rametta Giuliano, S. / Bordonaro, S. / Lanteri, E. / Tralongo, P. et al. | 2015
- 1270
-
Concomitant ALK translocation and other non-EGFR gene in NSCLC: knowledge in the makingPassaro, A. / Barberis, M. / Catania, C. / Pessina, S. / de Marinis, F. et al. | 2015
- 1272
-
Reply to the letter to the editor ‘Potential clinical relevant drug–drug interactions: comparison between different compendia, do we have a validated method?’ by Conde-Estévez et al.van Leeuwen, R. W. / Mathijssen, R. H. / Jansman, F. G. / van Gelder, T. et al. | 2015
- 1272
-
Potential clinical relevant drug–drug interactions: comparison between different compendia, do we have a validated method?Conde-Estévez, D. / Echeverría-Esnal, D. / Tusquets, I. / Albanell, J. et al. | 2015
- 1274
-
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events| 2015